论文部分内容阅读
高翔黑龙江哈尔滨人,1996年创建哈尔滨圣泰制药有限公司;与中国医学科学院合作研发新药.其中两个品种填补领域空白,一个品种被列为国家“十五”重点攻关项目;累计为社会公益事业捐款捐物价值达2200多万元,非典期间,将全公司生产的主要抗非典药品的百分之八十捐赠给了社会,研究开发了治疗非典新药“西维来司纳”。《中国青年》:你认为自己获奖的理由是什么?高翔:是改革开放的好政策和市场经济环境为我们这一代人创造了广阔的发展空间,是时代造就了我们,是党和政府的培养使我得到了社会和人民的认可。我
Gaoxiang Harbin, Heilongjiang, Harbin Shengtai Pharmaceutical Co., Ltd. was established in 1996. Cooperated with the Chinese Academy of Medical Sciences in the research and development of new drugs, of which two varieties to fill the gaps in the field, a species is listed as the national “fifteen” key project; accumulated for the community During the period of SARS, 80% of the major anti-SARS drugs produced by the whole company were donated to the society and the research and development of new drugs for the treatment of SARS . “China Youth”: What do you think of the reasons for winning the award? Gao Xiang: It is a good policy of reform and opening up and the market economy has created a vast space for development for our generation. It is the time that has created us and the party and the government I got the approval of society and people. I